Skip to main content

Table 1 SNP-array and karyotype results of 15 fetuses with ROH

From: Chromosomal microarray analysis for prenatal diagnosis of uniparental disomy: a retrospective study

No

SNP-array (ROH)

Chromosome

Size (Mb)

Indications

Karyotype

Follow-up

1

arr[hg19] 6q13q14.1(71116171_83031752) × 2 hmz

6

12.0

High risk of serum screening

46,XY,inv(9)(p12q13)

Two-years-old growth and development is normal

2

arr[GRCh37] 6q14.1q15(79854364_89916843) × 2 hmz

6

10.0

Ultrasound soft marker

46,XY

one-year-old growth and development is normal

3

arr[GRCh37]6q22.31q23.2(123304566_134548143) × 2hmz (paternal UPD)

6

11.2

Thickened nuchal fold Agenesis of the corpus callosum; High risk of serum screening; High risk of neural tube defects

46,XY

TOP

4

arr[hg19] 7q31.2q32.1(115333496_128333758) × 2 hmz

7

13.0;12.7

Thickened nuchal translucency

46,XX

A female infant with normal external examination

5

arr[hg19] 7q33q36.3(137994712_157061474) × 2 hmz

7

19.1

First trimester medication history

46,XY

A male infant with normal external examination

6

arr[GRCh37]7q11.23q22.1(74069645_102039696) × 2 hmz (maternal UPD)

7

28.0

Both spouses have thalassemia

CVS karyotype:mos 47,XY, + 7[21]/46,XY,[44]; AF karyotype: 46,XY

TOP

7

arr[hg19] 11p13q13.3(32228901_69217423) × 2 hmz

11

37.0

High risk of serum screening

46,XY

A male infant with normal external examination

8

arr[GRCh37] 11q13.4q14.2(75162918_87295319) × 2 hmz (exclude UPD)

11

12.1

Advanced maternal age

46,XY

A male infant with normal external examination

9

arr[GRCh37] 11p15.1p14.1(18804524_30833779) × 2 hmz (exclude UPD)

11

12.0

Get a COVID-19 vaccine in the first trimester

46,XX

A female infant with normal external examination

10

arr[GRCh37] 11p15.5p15.1(230751_20060445) × 2 hmz

11

19.8

Thickened nuchal fold; ultrasound soft marker

46,XY

9 months old growth and development is normal

11

arr[GRCh37] 11p11.2q13.2(44287149_68239940) × 2 hmz

11

23.9

Both spouses are intellectual disability

46,XY

TOP

12

arr[GRCh37] 11p15.3p14.3(12110677_23047939) × 2 hmz

11

10.9

Thickened nuchal translucency; Pervious adverse pregnancies

46,XY

6 months old growth and development is normal

13

arr[GRCh37]14q11.2q32.33(20520198_107279475) × 2 hmz (paternal UPD)

14

Chromosome 14

Thickened nuchal fold; Agenesis of the corpus callosum

46,XY

TOP

14

arr[hg19] 15q21.1q22.2(48335576_60931242) × 2 hmz (exclude UPD)

15

12.6

Thickened nuchal translucency; Cardiac abnormalities

46,XX

TOP

15

arr[GRCh37] 20q11.21q12(29510307_40604830) × 2 hmz

20

11.1

Fetal bowel echo enhancement, left ventricular intense spot

46,XX

18 months old growth and development is normal

  1. TOP: termination of pregnancy
  2. Thickened nuchal translucency (NT): NT > 3.0 mm; Thickened nuchal fold (NF): NF > 6.0 mm